Allergy & Rhinology

About Allergy & Rhinology

Allergy & Rhinology — Full Journal Profile

Allergy & Rhinology was an open access, peer-reviewed medical specialty journal devoted to allergy and to rhinology — the study and treatment of the nose, sinuses and related structures. It began with volume 1, number 1 in January 2010 and, according to the ISSN record, ceased with volume 13 in 2022. That single fact shapes everything else in this profile, and it is stated at the top deliberately: this is a completed journal archive, not a currently accepting title. Its articles remain readable, citable and clinically interesting — its back file sits in PubMed Central — but no new manuscript can be submitted to it, and any website that invites submissions in its name today should be treated with great caution.

The journal's online ISSN is 2152-6567, the identifier carried on this JournalsWorld record, shown in its article DOIs, and recorded for the online edition in the ISSN Portal, which also records a print ISSN of 2152-6575. It was founded under Oceanside Publications of Providence, Rhode Island, and its latest publisher of record was SAGE Publications — SAGE Publishing in the Directory of Open Access Journals (DOAJ) record, with SAGE's base given as Thousand Oaks, California in the ISSN record. Its subject home is the meeting point of two clinical fields: immunologic disease and allergy on one side, and otorhinolaryngology — ear, nose and throat medicine — on the other.

Quick facts

Several entries in this table are deliberately labelled historical. Fees, timelines and submission arrangements describe how the journal operated while it was publishing; they have no present-day application, because the journal is no longer publishing. A profile that presented them in the present tense, without the cessation, would risk sending an author to look for a submission portal that no longer exists — or worse, into the hands of a fraudulent site trading on a ceased journal's name, a known pattern in scholarly publishing fraud. The honest statement of status is therefore not a footnote to this profile; it is one of its most useful facts.

Identity and the journals it must not be confused with

The closest source of confusion is the American Journal of Rhinology & Allergy, a separate and still distinct title, also associated with SAGE, whose identifiers are entirely different — print ISSN 1945-8924 and online ISSN 1945-8932 in the cataloguing consulted alongside this profile — and whose history reaches back well before 2010. The two titles share a publisher, a specialty and two of their three title words, and their articles are interleaved in search results, in reference lists and even in some secondary databases. They are not the same journal. Allergy & Rhinology is the 2010–2022 open access title with online ISSN 2152-6567; the American Journal of Rhinology & Allergy is the other title, and citations, metrics and editorial arrangements belonging to one must never be transferred to the other.

A second confusion is with allergy journals in general. Titles such as Allergy, the Journal of Allergy and Clinical Immunology and their companions occupy the immunology side of the field, while Allergy & Rhinology sat specifically at the ENT–allergy interface: the nose and sinuses as allergic organs, and allergic disease as it presents to the rhinologist and the otolaryngologist. Its abbreviated key title in the ISSN record, Allergy rhinol. (Providence R.I.), preserves its founding place, Providence, Rhode Island, home of Oceanside Publications, and is a useful fingerprint in older citations. Where a citation gives the abbreviation, the place qualifier helps confirm that the Providence title — this journal — is meant.

Identification in practice is, as always, an ISSN exercise. An article whose DOI begins 10.1177/21526567 — the SAGE prefix followed by the journal's online ISSN embedded in the article number, a pattern visible throughout its later volumes — and whose journal title is Allergy & Rhinology belongs to this journal. This JournalsWorld page's own automatically matched recent-article list, drawn by ISSN, shows exactly that pattern across its 2021 and 2022 items, which independently corroborates the identity of the record.

History: from Oceanside Publications to SAGE, 2010–2022

The journal began in January 2010 under Oceanside Publications, a Providence, Rhode Island publisher known for ENT and allergy titles, and DOAJ records it as publishing in open access from 2011 — early adoption of open access for a clinical specialty journal of that period. Its model was the one its specialty needed: case reports, clinical studies, reviews and technique papers that clinicians could read without a subscription barrier, financed on the author side by article processing charges, recorded by DOAJ at up to 2,650 US dollars with a waiver policy for authors who could not pay.

During its life the title passed to SAGE Publications, recorded as its latest publisher, with the journal presented on the SAGE Journals platform under the title code AAR — the code visible in the SAGE aims, author instructions and editorial board addresses preserved in the DOAJ record. The article numbering of its later years reflects the SAGE system: continuous online publication within an annual volume, with long article identifiers rather than conventional page ranges, as the 2021 and 2022 articles listed on this JournalsWorld page illustrate. The ISSN record, last modified in 2024, closes the story: publication dates 2010 to 2022, status ceased, final volume 13.

A ceased journal is not a failed journal, and readers should not read the cessation as a quality verdict. Specialty titles end for commercial and portfolio reasons at large publishers, and the scholarly test of this one is the archive it left: thirteen volumes of peer-reviewed work, preserved in PubMed Central, continuing to be cited — as the 2021–2022 items on COVID-19-related smell loss, vaccine case reports, rhinosinusitis management and immunodeficiency case series, all visible in this record's article list, have continued to attract readers well beyond the journal's own lifetime. The correct scholarly posture towards a ceased title is to use its archive with the same critical care as any literature, to cite it accurately with its dates, and never to pretend, in a CV, a thesis or a journal marketing page, that it is still a going concern.

Scope in detail

DOAJ classifies the journal under Otorhinolaryngology and under Immunologic diseases. Allergy, and records its keywords as allergy, rhinology, otolaryngology, pathophysiology, sinonasal disease and allergic disorders. Its clinical territory, as reflected in its published archive, breaks down as follows.

Sinonasal disease and rhinology

The core of the journal was the nose and paranasal sinuses: chronic rhinosinusitis with and without nasal polyps, acute sinusitis and its orbital and intracranial complications, sinonasal surgery and its techniques, and disorders of smell and taste. Articles in this strand include surgical analyses, management strategies for complications, and systematic work on diagnosis — including, in its final volumes, extensive work on olfactory dysfunction connected with COVID-19, a topic on which a rhinology journal was uniquely placed to publish during 2020–2022. Clinicians reading this archive today should allow for the movement of guidelines since publication, especially in fast-moving areas such as biologics for chronic rhinosinusitis with nasal polyps, where the journal published practical monitoring protocols in its last years.

Allergy and immunologic disease

The second pillar was allergy as a clinical and immunological discipline: allergic rhinitis and its diagnosis, allergen-specific and total immunoglobulin E testing, urticaria, asthma in its sinonasal connections, humoral immunodeficiency and its presentations, and vaccine-related case reports. Pollen allergy screening, chronic spontaneous urticaria, and COVID-19 infection in patients with antibody deficiency all appear in its closing volumes, illustrating a scope that ran from laboratory-guided diagnosis to individual case reasoning. The pathophysiology keyword in its DOAJ record signals that mechanistic work — why allergic and sinonasal disease happens, not only how it is treated — was in scope alongside clinical studies.

Article types: research, reviews, trials and case reports

The journal published original research, clinical studies, review articles and case reports, including systematic reviews and single-case and case-series writing. That mixture is characteristic of a practice-facing specialty journal: a case report of an inverted papilloma of the middle ear, a protocol for monitoring patients on biologics, and a systematic review of anosmia diagnosis serve different readers in the same issue. Readers using the archive should weight those article types appropriately — a case report generates hypotheses and alerts clinicians to rare presentations; it does not establish treatment effects — and authors citing the journal should cite the type accurately rather than letting a narrative review harden, through citation, into supposed primary evidence.

The unified airway in practice

Running through the scope is the clinical idea that the upper and lower airways behave as one system: allergic rhinitis, chronic rhinosinusitis, asthma and related disorders interact, and a journal that housed rhinologists and allergists together was built to publish work at that junction — factors affecting control of rhinosinusitis in patients with or without NSAID-exacerbated respiratory disease, for instance, or smell and taste disorders in children with COVID-19. For a modern reader, that junction remains the journal's distinctive value; its archive is a compact place to see how the two specialties reasoned together over a decade.

Peer review, editorial practice and the terms on which it published

While it published, the journal operated single anonymous peer review, with plagiarism screening, as recorded by DOAJ, which also recorded an average of about fifteen weeks from submission to publication, an editorial board presented on the SAGE platform, and author instructions maintained there. These are the standard arrangements of a professionally published clinical journal of its period, and they are recorded here as part of the archive's provenance: a reader assessing a 2015 or a 2021 article from this journal is entitled to know that it passed through anonymous external review and screening at a established publisher, first Oceanside and then SAGE, before it entered PubMed Central.

Its open access terms were a Creative Commons Attribution licence or an Attribution–NonCommercial licence — CC BY or CC BY-NC in the DOAJ record — with authors not retaining unrestricted copyright and publishing rights. In practice that means most articles in the archive can be shared freely with attribution, and many can be reused more broadly, but the licence printed on the individual article is the governing statement: CC BY and CC BY-NC permit different uses, especially commercial ones, and anyone reusing text or figures — in teaching, in a thesis, in a commercial product — should read the licence on the article itself rather than assuming the journal applied one licence uniformly across thirteen volumes and two publishers.

The article processing charge recorded by DOAJ, up to 2,650 US dollars with waivers, is included for completeness of the historical record. It explains the journal's economics while it lived — reader-free, author-side funded, with a waiver route — and it has one present-day use: as a warning template. Because the journal has ceased, no legitimate charge in its name can now arise. A request for payment to submit to, or publish in, Allergy & Rhinology received today cannot come from the journal's real publisher for a real submission, and should be reported and ignored.

Archiving, indexing presence and verification

The journal's preservation home is PubMed Central, recorded by DOAJ and visible in the National Library of Medicine's journal list, which is the right long-term arrangement for a ceased clinical title: the archive does not depend on a publisher's marketing platform remaining online. Articles carry DOIs, and the SAGE-period DOIs resolve through the standard DOI system. The journal was listed in DOAJ throughout the open access period covered by that record, which documents its stated review, licensing and charging practices as they stood while it published.

This profile makes no claim of a current impact factor, CiteScore or ranking for the journal, for two reasons that readers should generalise. First, a ceased journal's metrics are historical artefacts tied to specific years and providers, and quoting one without its year invites error. Second, the numbers most often attached to this title in third-party summaries belong in several cases to the American Journal of Rhinology & Allergy or to aggregator estimates that could not be verified against a provider's own listing for ISSN 2152-6567. A reader who needs the journal's standing in a particular year should consult that provider's archive for that year, searching by ISSN, and cite the result with its year attached.

To verify an article from the archive: match the journal title and online ISSN 2152-6567; resolve the DOI and confirm that authors, title and volume agree with the citation; and read the version of record through PubMed Central or the publisher's archive. If a supposed article in this journal is dated after volume 13 of 2022, it cannot belong to the journal as the ISSN record describes it, and the citation should be re-examined — most such cases turn out to be the American Journal of Rhinology & Allergy, a different year, or a straightforward error in a reference list.

For authors: what the cessation means in practice

Authors cannot submit to this journal, and this profile will not pretend otherwise. The practical guidance that follows from its story is nonetheless real. Authors with work in its territory — sinonasal disease, allergic disorders, the ENT–allergy interface — should look to currently publishing titles in the same specialty, verify on the publisher's own site that the title is active and accepting submissions, and confirm its ISSN and indexing there before submitting. Authors whose earlier work appeared in Allergy & Rhinology can cite it normally: cessation does not disturb the citability of the archive, and the PubMed Central copies provide stable access for readers following those citations. Authors preparing a CV or a grant publication list should give the journal's correct title, years and ISSN, and should take care — a common clerical error in this specialty — not to upgrade the citation, accidentally or otherwise, into the American Journal of Rhinology & Allergy.

Frequently asked questions

Is Allergy & Rhinology still publishing? No. The ISSN record gives publication dates of 2010–2022 and status ceased, ending with volume 13 in 2022. Its archive remains available, principally through PubMed Central.

What are its ISSNs? Online ISSN 2152-6567, with print ISSN 2152-6575 recorded for the print edition. The online ISSN is embedded in its SAGE-period article numbers, 10.1177/21526567…

Who published it? It began under Oceanside Publications of Providence, Rhode Island, in 2010; its latest publisher was SAGE Publications in the United States.

Is it the same as the American Journal of Rhinology & Allergy? No. That is a separate title with different ISSNs (1945-8924 / 1945-8932). The similarity of name, specialty and publisher makes the ISSN check essential.

Was it peer reviewed and open access? Yes on both counts while it published: single anonymous peer review with plagiarism screening, and open access from 2011 under CC BY or CC BY-NC licences, as recorded by DOAJ.

Can I still read and cite its articles? Yes. Articles remain available through PubMed Central and by DOI, and they should be cited in the normal way, with the correct journal title and year.

Sources and verification note

This profile rests on the ISSN Portal record for 2152-6567 — abbreviated key title, publishers, dates 2010–2022, ceased status, volume history and country — on the journal's DOAJ record — SAGE Publishing as publisher, English language, subjects and keywords, single anonymous review, plagiarism screening, fifteen-week publication time, open access from 2011, CC BY and CC BY-NC licensing, article charges and waiver policy, DOI provision and PubMed Central archiving — on the SAGE platform addresses preserved in that record, on the National Library of Medicine's archiving of the title in PubMed Central, and on this JournalsWorld record, whose ISSN and whose ISSN-matched article list for 2021–2022 agree with those sources. Where a point could not be verified from those official sources, it has been left out or described as not published, not publicly disclosed, or could not be verified. In particular, no current metric is claimed for a journal that ceased in 2022, and no submission route is described for a title that no longer accepts submissions.